Cargando…
USP22 Suppresses SPARC Expression in Acute Colitis and Inflammation-Associated Colorectal Cancer
SIMPLE SUMMARY: Intestinal inflammation leads to an increased risk of developing colorectal cancer (CRC) and incidences are expected to rise. Therefore, it is crucial to identify molecular factors contributing to these medical conditions. In an earlier study, we identified USP22 as a tumor suppresso...
Autores principales: | Kosinsky, Robyn Laura, Saul, Dominik, Ammer-Herrmenau, Christoph, Faubion, William A., Neesse, Albrecht, Johnsen, Steven A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070211/ https://www.ncbi.nlm.nih.gov/pubmed/33920268 http://dx.doi.org/10.3390/cancers13081817 |
Ejemplares similares
-
The microbiome in pancreatic diseases: Recent advances and future perspectives
por: Ammer-Herrmenau, Christoph, et al.
Publicado: (2020) -
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response
por: Prokakis, Evangelos, et al.
Publicado: (2021) -
The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022) -
Usp22 deficiency impairs intestinal epithelial lineage specification in vivo
por: Kosinsky, Robyn L., et al.
Publicado: (2015) -
Cell Type-Specific Induction of Inflammation-Associated Genes in Crohn’s Disease and Colorectal Cancer
por: Saul, Dominik, et al.
Publicado: (2022)